Abstract |
Immune responses to cancer vaccines are commonly tested by measuring cutaneous reactions to intradermal (i.d.) antigen. When well-characterized peptide epitopes are injected i.d., infiltrates of CD4+ and CD8+ T lymphocytes are frequently seen. In this study, we have further characterized T cells derived from vaccine-infiltrating lymphocyte (VIL) responses. We found that the infiltrates capable of producing IFN-gamma and cytolytic activity could recognize vaccine peptide, as well as antigen-positive melanoma cells. We studied antigen-specific T cell responses from VILs and peripheral blood in 10 patients who participated in a clinical trial. All patients received systemic Flt3 ligand (20 microg/kg/d) and i.d. peptides: Three NY-ESO-1 peptides, SLLMWITQCFL (157-167), SLLMWITQC (157-165), QLSLLMWIT (155-163); tyrosinase internal peptide YMDGTMSQV (368-376); Melan-A/MART-1 analogue peptide ELAGIGILTV (26-35, E27L substitution); and influenza matrix peptide GILGFVFTL (58-66). In 54 paired VIL and peripheral blood analyses, a good correlation was found between responses in skin and in blood. These cells could be rapidly expanded in a short-term assay and thus appear to be memory T cells. The demonstrated presence of antigen-specific T cells at vaccination sites validates this method of assessing the immune response to i.d. vaccines.
|
Authors | Qiyuan Chen, Heather Jackson, Mark Shackleton, Phillip Parente, Wendie Hopkins, Sue Sturrock, Duncan MacGregor, Eugene Maraskovsky, Tsin Yee Tai, Nektaria Dimopoulos, Kelly-Anne Masterman, Tina Luke, Ian D Davis, Weisan Chen, Jonathan Cebon |
Journal | Cancer immunity
(Cancer Immun)
Vol. 5
Pg. 5
(Mar 09 2005)
ISSN: 1424-9634 [Electronic] United States |
PMID | 15755075
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- Cancer Vaccines
- Vaccines, Subunit
- Interferon-gamma
|
Topics |
- Antigens, Neoplasm
(immunology)
- Blood Cells
(immunology)
- CD4-Positive T-Lymphocytes
(immunology)
- CD8-Positive T-Lymphocytes
(immunology)
- Cancer Vaccines
(administration & dosage, immunology)
- Cell Line, Tumor
- Cytotoxicity Tests, Immunologic
- Humans
- Hypersensitivity, Delayed
(immunology)
- Injections, Intradermal
- Interferon-gamma
(biosynthesis)
- Lymphocytes, Tumor-Infiltrating
(immunology)
- Melanoma
(immunology)
- Skin
(immunology)
- Skin Neoplasms
(immunology)
- Vaccines, Subunit
(administration & dosage, immunology)
|